An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)

NCT07456696 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Post Traumatic Stress Disorder

Interventions

DRUG: TSND-201
DRUG: Placebo

Sponsor

Transcend Therapeutics